Li CC - Search Results

1

[Clinical Features and Prognostic of Patients with Primary Central Nervous System Lymphoma].

Zhang LT, Li CC, Jin QQ, Jiang HY, Yue NN, Zeng PY, Yue LL, Wu CY. Zhang LT, et al. Among authors: li cc. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Jun;32(3):723-732. doi: 10.19746/j.cnki.issn.1009-2137.2024.03.011. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024. PMID: 38926959 Chinese.

2

Frequent Gene Mutations and Their Possible Roles in the Pathogenesis, Treatment and Prognosis of Primary Central Nervous System Lymphoma.

Jin Q, Jiang H, Han Y, Li C, Zhang L, Zhang Y, Chai Y, Zeng P, Yue L, Wu C. Jin Q, et al. World Neurosurg. 2023 Feb;170:99-106. doi: 10.1016/j.wneu.2022.11.056. Epub 2022 Nov 15. World Neurosurg. 2023. PMID: 36396049 Review.

3

CD39 (ENTPD1) in tumors: a potential therapeutic target and prognostic biomarker.

Li C, Zhang L, Jin Q, Jiang H, Wu C. Li C, et al. Biomark Med. 2023 Jun;17(12):563-576. doi: 10.2217/bmm-2023-0202. Epub 2023 Sep 15. Biomark Med. 2023. PMID: 37713234 Review.

4

Role and application of chemokine CXCL13 in central nervous system lymphoma.

Li C, Zhang L, Jin Q, Jiang H, Wu C. Li C, et al. Ann Hematol. 2024 Aug;103(8):2671-2680. doi: 10.1007/s00277-023-05560-4. Epub 2023 Nov 27. Ann Hematol. 2024. PMID: 38010409 Review.

5

The prognostic value of CD8⁺ CTLs, CD163⁺ TAMs, and PDL1 expression in the tumor microenvironment of primary central nervous system lymphoma.

Jin Q, Jiang H, Yue N, Zhang L, Li C, Dong C, Zeng P, Yue L, Wu C. Jin Q, et al. Leuk Lymphoma. 2024 Apr;65(4):472-480. doi: 10.1080/10428194.2023.2296364. Epub 2024 Jan 10. Leuk Lymphoma. 2024. PMID: 38198635

6

[Whole Exome Sequencing Reveals Gene Mutation Characteristics of Primary Central Nervous System Lymphoma].

Jin QQ, Jiang HY, Han Y, Li CC, Zhang LT, Wu CY. Jin QQ, et al. Among authors: li cc. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Jun;32(3):756-762. doi: 10.19746/j.cnki.issn.1009-2137.2024.03.015. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024. PMID: 38926963 Chinese.

7

CD36: a promising therapeutic target in hematologic tumors.

Yue N, Jin Q, Li C, Zhang L, Cao J, Wu C. Yue N, et al. Leuk Lymphoma. 2024 Dec;65(12):1749-1765. doi: 10.1080/10428194.2024.2376178. Epub 2024 Jul 9. Leuk Lymphoma. 2024. PMID: 38982639 Review.

8

Recent advances in CD5⁺ diffuse large B-cell lymphoma.

Yue N, Jin Q, Li C, Zhang L, Cao J, Wu C. Yue N, et al. Ann Hematol. 2024 Nov;103(11):4401-4412. doi: 10.1007/s00277-024-05974-8. Epub 2024 Aug 28. Ann Hematol. 2024. PMID: 39196380 Review.

9

Tumor microenvironment in primary central nervous system lymphoma (PCNSL).

Jin Q, Jiang H, Han Y, Zhang L, Li C, Zhang Y, Chai Y, Zeng P, Yue L, Wu C. Jin Q, et al. Cancer Biol Ther. 2024 Dec 31;25(1):2425131. doi: 10.1080/15384047.2024.2425131. Epub 2024 Nov 18. Cancer Biol Ther. 2024. PMID: 39555697 Free PMC article. Review.

10

Visible-Light Photocatalyzed Skeletal Rearrangement Enables the Synthesis of Highly Functionalized Xanthenes with Antitumor Activity.

Lin SL, Zhao F, Wei F, Shi YT, Wen JK, Yang C, Zhang HS, Li CC, Liu C, Ye WC, Cheng MJ, Wang L. Lin SL, et al. Among authors: li cc. Angew Chem Int Ed Engl. 2024 Dec 23:e202420671. doi: 10.1002/anie.202420671. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 39714462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,715 results

Search Page

Filters